Opus Genetics Company Insiders

Opus Genetics Management Team Effectiveness

The company has Return on Asset of (0.6074) % which means that on every $100 spent on assets, it lost $0.6074. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (3.3875) %, meaning that it generated no profit with money invested by stockholders. Opus Genetics' management efficiency ratios could be used to measure how well Opus Genetics manages its routine affairs as well as how well it operates its assets and liabilities. As of January 2, 2026, Return On Tangible Assets is expected to decline to -1.47. The current year's Return On Capital Employed is expected to grow to -2.65. At present, Opus Genetics' Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Asset Turnover is expected to grow to 0.30, whereas Total Current Assets are forecasted to decline to about 33.9 M. As of January 2, 2026, Common Stock Shares Outstanding is expected to decline to about 17.5 MOpus Genetics owns a total of 68.96 Million outstanding shares. Opus Genetics holds significant amount of outstanding shares owned by insiders and institutional investors . Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Opus Genetics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Opus Genetics, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Opus Genetics Workforce Comparison

Opus Genetics Insider Trading

Opus Genetics Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Opus Genetics often depends on how effective the management is. Opus Genetics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Opus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Opus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Opus Genetics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Opus Genetics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Opus Genetics' management manipulating its earnings.

When running Opus Genetics' price analysis, check to measure Opus Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opus Genetics is operating at the current time. Most of Opus Genetics' value examination focuses on studying past and present price action to predict the probability of Opus Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opus Genetics' price. Additionally, you may evaluate how the addition of Opus Genetics to your portfolios can decrease your overall portfolio volatility.